Molecular Response to Neoadjuvant Chemotherapy in High-Grade Serous Ovarian Carcinoma

Ovarian Carcinoma ◽

Molecular Response ◽

High Grade ◽

Response To Neoadjuvant Chemotherapy

Molecular response to neoadjuvant chemotherapy in high-grade serous ovarian carcinoma

Gynecologic Oncology ◽

10.1016/j.ygyno.2016.04.396 ◽

2016 ◽

Vol 141 ◽

pp. 151-152

Author(s):

R.C. Arend ◽

Z.C. Dobbin ◽

D.K. Crossman ◽

B.K. Erickson ◽

J.D. Boone ◽

...

Keyword(s):

Ovarian Carcinoma ◽

Molecular Response ◽

High Grade ◽

Response To Neoadjuvant Chemotherapy

Molecular response to neoadjuvant chemotherapy in high-grade serous ovarian carcinoma

Gynecologic Oncology ◽

10.1016/j.ygyno.2017.03.046 ◽

2017 ◽

Vol 145 ◽

pp. 12-13

Author(s):

A.M. Montgomery ◽

D.K. Crossman ◽

E.S. Yang ◽

R.D. Alvarez ◽

W.K. Huh ◽

...

Keyword(s):

Ovarian Carcinoma ◽

Molecular Response ◽

High Grade ◽

Response To Neoadjuvant Chemotherapy

394 CA125 normalization following neoadjuvant chemotherapy complementing the chemotherapy response system in the prognostication of patients with high-grade serous ovarian carcinoma

10.1136/ijgc-2020-igcs.341 ◽

2020 ◽

Author(s):

J Li ◽

M Wu ◽

L Wang ◽

Z Lin

Keyword(s):

Ovarian Carcinoma ◽

Chemotherapy Response ◽

High Grade ◽

Response System ◽

Surgical factors do not impact survival in high-grade serous ovarian carcinoma patients treated with neoadjuvant chemotherapy

Gynecologic Oncology ◽

10.1016/j.ygyno.2015.01.100 ◽

2015 ◽

Vol 137 ◽

pp. 43

Author(s):

J.M. Stewart ◽

A.A. Tone ◽

M.Q. Bernardini ◽

S.E. Ferguson ◽

J. Dodge ◽

...

Keyword(s):

Ovarian Carcinoma ◽

High Grade ◽

Improvement of radiological disease on CT after neoadjuvant chemotherapy may not correlate with chemotherapy response score (CRS) in advanced tubo-ovarian high-grade serous ovarian carcinoma

Gynecologic Oncology ◽

10.1016/j.ygyno.2019.04.266 ◽

2019 ◽

Vol 154 ◽

pp. 110-111 ◽

Cited By ~ 1

Author(s):

R. Sugrue ◽

K. James ◽

W.B. Growdon ◽

R.M. Clark ◽

M.G. del Carmen ◽

...

Keyword(s):

Ovarian Carcinoma ◽

Chemotherapy Response ◽

High Grade ◽

Response Score

Elastography, a sensitive tool for the evaluation of neoadjuvant chemotherapy in patients with high-grade serous ovarian carcinoma

Oncology Letters ◽

10.3892/ol.2014.2346 ◽

2014 ◽

Vol 8 (4) ◽

pp. 1652-1656 ◽

Cited By ~ 5

Author(s):

MENG XIE ◽

XUYIN ZHANG ◽

ZHAN JIA ◽

YUNYUN REN ◽

WENPING WANG

Keyword(s):

Ovarian Carcinoma ◽

High Grade ◽

Sensitive Tool

Role of systematic pelvic and para‐aortic lymphadenectomy in delayed debulking surgery after six neoadjuvant chemotherapy cycles for high‐grade serous ovarian carcinoma

Journal of Obstetrics and Gynaecology Research ◽

10.1111/jog.14838 ◽

2021 ◽

Author(s):

Andre Lopes ◽

Maria L. N. D. Genta ◽

Vanessa Costa Miranda ◽

Andrea Aranha ◽

Rossana V. M. Lopez ◽

...

Keyword(s):

Ovarian Carcinoma ◽

High Grade ◽

Debulking Surgery ◽

47 Impact of systematic pelvic and para-aortic lymphadenectomy after six cycles of neoadjuvant chemotherapy in high-grade serous ovarian carcinoma

10.1136/ijgc-2019-igcs.47 ◽

2019 ◽

Author(s):

A Lopes ◽

ML Nogueira D Genta ◽

RV Mendonza Lopez ◽

M del Pilar Estevez Diz ◽

J Paula Carvalho

Keyword(s):

Ovarian Carcinoma ◽

High Grade ◽

Investigation of intratumoral heterogeneity in high-grade serous ovarian carcinoma amongst treatment naïve tumors and tumors treated with neoadjuvant chemotherapy

Gynecologic Oncology ◽

10.1016/j.ygyno.2015.09.041 ◽

2015 ◽

Vol 139 (3) ◽

pp. 590-591

Author(s):

Tarra Evans ◽

Brooke Howitt ◽

Christopher Crum ◽

Ross Berkowitz ◽

Shu-Wing Ng

Keyword(s):

Ovarian Carcinoma ◽

Intratumoral Heterogeneity ◽

High Grade ◽

Treatment Naïve

THE EXPRESSION OF THE PI3K/AKT/mTOR PATHWAY AS A PROGNOSTIC FACTOR IN PATIENTS WITH ADVANCED HIGH GRADE SEROUS OVARIAN CARCINOMA TREATED WITH NEOADJUVANT CHEMOTHERAPY

10.26226/morressier.5770e29dd462b80290b4c255 ◽

2016 ◽

Author(s):

Lubomir Bodnar

Keyword(s):

Prognostic Factor ◽

Ovarian Carcinoma ◽

Mtor Pathway ◽

High Grade ◽